Cargando…

Mechanisms of immune checkpoint inhibitor-mediated liver injury

The immune checkpoints, cytotoxic T-lymphocyte-associated antigen 4 (CTLA-4) and programmed cell death protein-1/ligand-1 (PD-1/PD-L1) are vital contributors to immune regulation and tolerance. Recently immune checkpoint inhibitors (ICIs) have revolutionized cancer therapy; however, they come with t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shojaie, Layla, Ali, Myra, Iorga, Andrea, Dara, Lily
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8727893/ https://www.ncbi.nlm.nih.gov/pubmed/35024302 http://dx.doi.org/10.1016/j.apsb.2021.10.003

Ejemplares similares

Cell Death in Liver Diseases: A Review
por: Shojaie, Layla, et al.
Publicado: (2020)

Drug-Induced Liver Injury: Cascade of Events Leading to Cell Death, Apoptosis or Necrosis
por: Iorga, Andrea, et al.
Publicado: (2017)

Interaction of RIPK1 and A20 modulates MAPK signaling in murine acetaminophen toxicity
por: Iorga, Andrea, et al.
Publicado: (2021)

Mechanisms of resistance to immune checkpoint inhibitors
por: Jenkins, Russell W, et al.
Publicado: (2018)

Mechanism of resistance to immune checkpoint inhibitors
por: Pandey, Manu R., et al.
Publicado: (2019)

Mechanisms of Immune Checkpoint Inhibitor-Mediated Colitis
por: Westdorp, Harm, et al.
Publicado: (2021)

Mechanisms of resistance to immune checkpoint inhibitors
por: Nagasaki, Joji, et al.
Publicado: (2022)

Epigenetic Mechanisms of Resistance to Immune Checkpoint Inhibitors
por: Perrier, Alexandre, et al.
Publicado: (2020)

An analysis report on the application of immune checkpoint inhibitors after liver transplantation
por: Xie, Man, et al.
Publicado: (2022)

Myocarditis Induced by Immune Checkpoint Inhibitors: Mechanisms and Therapeutic Prospects
por: Zou, Wenlu, et al.
Publicado: (2021)

Mechanisms of Primary and Secondary Resistance to Immune Checkpoint Inhibitors in Cancer
por: Seto, Tiffany, et al.
Publicado: (2019)

Clinical Features of Liver Injury Induced by Immune Checkpoint Inhibitors in Japanese Patients
por: Imoto, Koji, et al.
Publicado: (2019)

Cardiotoxicity of immune checkpoint inhibitors
por: Varricchi, Gilda, et al.
Publicado: (2017)

Capmatinib-Induced Liver Injury as Emerging Toxicity of MET Inhibitors in Patients With NSCLC Pretreated With Immune Checkpoint Inhibitors
por: Sisi, Monia, et al.
Publicado: (2023)

The Current Status of Immune Checkpoint Inhibitors in Neuro-Oncology: A Systematic Review
por: Brahm, Cyrillo G., et al.
Publicado: (2020)

Biologic and Checkpoint Inhibitor‐Induced Liver Injury: A Systematic Literature Review
por: Shah, Parth, et al.
Publicado: (2020)

Targeting nuclear acid-mediated immunity in cancer immune checkpoint inhibitor therapies
por: Chen, Miaoqin, et al.
Publicado: (2020)

Resumption of Immune Checkpoint Inhibitor Therapy After Immune-Mediated Colitis
por: Abu-Sbeih, Hamzah, et al.
Publicado: (2019)

Liver toxicity as a limiting factor to the increasing use of immune checkpoint inhibitors
por: De Martin, Eleonora, et al.
Publicado: (2020)

Molecular Mechanisms of Resistance to Immune Checkpoint Inhibitors in Melanoma Treatment: An Update
por: Vukadin, Sonja, et al.
Publicado: (2021)

The mechanisms of acute interstitial nephritis in the era of immune checkpoint inhibitors in melanoma
por: Marco, Tucci, et al.
Publicado: (2019)

Exploring the Mechanisms Underlying the Cardiotoxic Effects of Immune Checkpoint Inhibitor Therapies
por: Ronen, Daniel, et al.
Publicado: (2022)

Acute liver injury in the context of immune checkpoint inhibitor-related colitis treated with infliximab
por: Zhang, Hao Chi, et al.
Publicado: (2019)

Application of artificial liver in immune-related liver injury induced by immune checkpoint inhibitor: Case reports and review of the literature
por: Li, Xuewei, et al.
Publicado: (2022)

Atypical Antiglomerular Basement Membrane Nephritis Following Immune Checkpoint Inhibitor
por: Javaugue, Vincent, et al.
Publicado: (2022)

Immune Checkpoint Inhibitors in Prostate Cancer
por: Venkatachalam, Shobi, et al.
Publicado: (2021)

Immune Checkpoint Inhibitors in Special Populations
por: Shan, Qianyun, et al.
Publicado: (2021)

Immune checkpoint inhibitors in clinical trials
por: Sharon, Elad, et al.
Publicado: (2014)

Management of Immune Checkpoint Inhibitor Toxicities
por: Durrechou, Quentin, et al.
Publicado: (2020)

Cardiotoxicity from immune checkpoint inhibitors
por: Michel, Lars, et al.
Publicado: (2019)

The Potential Cardiotoxicity of Immune Checkpoint Inhibitors
por: Nardi Agmon, Inbar, et al.
Publicado: (2022)

Immune Checkpoint Inhibitors in Cancer Therapy
por: Shiravand, Yavar, et al.
Publicado: (2022)

Immune Checkpoint Inhibitors Related to Cardiotoxicity
por: Chen, Ru, et al.
Publicado: (2022)

Immune checkpoint inhibitors and their impact on liver enzymes and attenuation
por: Park, Benjamin C., et al.
Publicado: (2022)

Immune checkpoint therapy in liver cancer
por: Xu, Feng, et al.
Publicado: (2018)

Immune checkpoint inhibitor-mediated colitis in gastrointestinal malignancies and inflammatory bowel disease
por: Weingarden, Alexa R, et al.
Publicado: (2021)

Liver Transplantation for Hepatocellular Carcinoma after Downstaging or Bridging Therapy with Immune Checkpoint Inhibitors
por: Gao, Qimeng, et al.
Publicado: (2021)

Immune Checkpoint Inhibitors as Therapy to Down-Stage Hepatocellular Carcinoma Prior to Liver Transplantation
por: Katariya, Nitin N., et al.
Publicado: (2022)

Mechanisms and Management of Immune Checkpoint Inhibitor-Related Cardiac Adverse Events
por: Kadowaki, Hiroshi, et al.
Publicado: (2021)

Immune checkpoint inhibitors in bone metastasis: Clinical challenges, toxicities, and mechanisms
por: Joseph, Gwenyth J., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_luai54o03ujgs04a49ciluibs3